Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
By Qihui Wang, Yanfang Zhang, Lili Wu, S. Niu, Chunli Song, Zengyuan Zhang, Guangwen Lu, C. Qiao, Yu Hu, Kwok-Yung Yuen and 4 more. 2020
2,653 citations recorded by the source corpus.
The recent emergence of a novel coronavirus (SARS-CoV-2) in China has caused significant public health concerns. Recently, ACE2 was reported as an entry receptor for SARS-CoV-2. In this study, we present the crystal structure of the C-terminal domain of SARS-CoV-2 (SARS-CoV-2-CTD) spike (S) protein in complex with human ACE2 (hACE2), which reveals a hACE2-binding mode similar overall to that observed for SARS-CoV. However, atomic details at the binding interface demonstrate that key residue substitutions in SARS-CoV-2-CTD slightly strengthen the interaction and lead to higher affinity for receptor binding than SARS-RBD. Additionally, a panel of murine monoclonal antibodies (mAbs) and polyclonal antibodies (pAbs) against SARS-CoV-S1/receptor-binding domain (RBD) were unable to interact with the SARS-CoV-2 S protein, indicating notable differences in antigenicity between SARS-CoV and SARS-CoV-2. These findings shed light on the viral pathogenesis and provide important structural information regarding development of therapeutic countermeasures against the emerging virus.
Subfields: Animal Science and Zoology, Infectious Diseases
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Animal Science and Zoology
In Infectious Diseases
- D. Veesler
- A. Walls
- M. A. Tortorici
- F. Krammer
- Kwinten Sliepen
- F. Amanat
- Abdo A. Elfiky
- Wenshuai Wang
Citations in the corpus
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology (2020, positive): “Superimposition of the SARS-CoV-2 RBD/ACE2 structures (Lan et al., 2020; Shang et al., 2020; Wang et al., 2020b; Yan et al., 2020) onto the SARS-CoV-2 S/S2H13 complex reveals that S2H13 and ACE2 would clash upon binding to S and that they share partially overlapping binding sites although they have…”
- A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection (2020, background): “Multiple amino acid variations exist between SARS-CoV-2 and SARS-CoV RBDs and to a much larger extent between SARSCoV-2 and MERS-CoV RBDs (13, 50).”
- Structural Analysis of the SARS-CoV-2 Omicron Variant Proteins (2021, result): “The Omicron S1 RBD structure showed high similarities with the experimental structures (PDB: 6M17 and 6M0J) (Figures 1(d) and 1(e)), and the comparison of Omicron S1 RBD with experimental structures (PDB: 6M17[5], 6M0J [6], 6LZG [7], and 7JX3 [8]) showed low RMSD values (Figure 1(f)), which reflecte”
- Molecular Architecture of the SARS-CoV-2 Virus (2020, positive): “The S protein binds to the cellular surface receptor angiotensin-converting enzyme 2 (ACE2) through the receptor binding domain (RBD), an essential step for membrane fusion (Hoffmann et al., 2020; Lan et al., 2020; Shang et al., 2020; Wang et al., 2020; Yan et al., 2020; Zhou et al., 2020).”
- COVID-19: The first documented coronavirus pandemic in history (2020, neutral): “[23] Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, et al.”
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity (2020, positive): “It is possible that antibodies in convalescent sera are able to neutralize these critical epitopes targeted by these mAbs that are known to disrupt the binding of the S protein to hACE2 receptor (Ju et al., 2020; Shi et al., 2020; Walls et al., 2020; Wang et al., 2020).”